Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$2.35 - $4.66 $4,683 - $9,287
-1,993 Closed
0 $0
Q2 2022

Aug 22, 2022

SELL
$2.09 - $3.71 $1,214 - $2,155
-581 Reduced 22.57%
1,993 $6,000
Q2 2021

Aug 12, 2021

BUY
$10.15 - $17.25 $26,126 - $44,401
2,574 New
2,574 $41,000
Q2 2020

Aug 14, 2020

SELL
$1.41 - $2.61 $3,794 - $7,023
-2,691 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$4.03 - $9.22 $2,139 - $4,895
531 Added 24.58%
2,691 $12,000
Q1 2019

May 15, 2019

BUY
$13.6 - $19.58 $16,184 - $23,300
1,190 Added 122.68%
2,160 $33,000
Q3 2018

Nov 20, 2018

BUY
$24.32 - $37.54 $23,590 - $36,413
970 New
970 $31,000

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $30.8M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.